DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
7 articles
Colon cancer screening is no longer framed only around colonoscopy and stool tests: ACS now brings newer FDA-approved molecular options, including blood tests, into its guidance.
Pretargeted alpha therapy shows striking results in tumor models, but the clinical message must stay precise: this is not yet proof of a human therapy.
CANECPI-5, a sugarcane protein, is the key ingredient in this artificial saliva, which has shown promising results in early tests.
Four types of cancer were eliminated in mice using the new drugs.
New research in *Genetic Engineering & Biotechnology News* reveals how epigenetic alterations from gut inflammation endure long after healing, potentially setting the stage for colon cancer.
IB101’s defined binding pocket marks a structural advance, but the compound has yet to enter preclinical testing.
A single amino-acid change in an experimental T cell receptor improved prostate tumor killing in mouse models.
